MapLight Therapeutics (MPLT) Shares Outstanding (2024 - 2026)
MapLight Therapeutics (MPLT) posted Shares Outstanding (Entity) of $8.7 million for Q4 2025, up 974.33% sequentially from $808015.0 in Q3 2025, and up 1040.29% YoY from $761276.0 in Q4 2024.
MapLight Therapeutics (MPLT) Shares Outstanding (2024 - 2026) Analysis & Trends
MapLight Therapeutics has reported Shares Outstanding (Entity) for 2 years, with the latest figure at $8.7 million in Q4 2025.
- Quarterly Shares Outstanding (Entity) rose 1040.29% year-over-year to $8.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $8.7 million (up 1040.29% YoY) and the FY2025 annual result came in at $8.7 million, up 1040.29% from the prior year.
- Shares Outstanding (Entity) rose to $8.7 million in Q4 2025 per MPLT's latest filing, from $808015.0 in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $8.7 million in Q4 2025 and troughed at $758795.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | MapLight Therapeutics | 533.88 Mn | 533.88 Mn | - | 45.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 45.43 Mn |
| Dec 31, 2025 | 8.68 Mn |
| Sep 30, 2025 | 791,127.00 |
| Dec 31, 2024 | 736,178.00 |
| Sep 30, 2024 | 758,204.00 |